The Latest Breaking News from Health Care

Procter & Gamble Co (NYSE:PG) reported third-quarter FY22 sales growth of 7.1% year-on-year to $19.38 billion, beating the consensus of $18.73 billion. Organic sales increased 10%, driven by a 3% increase in shipment volume, 5% from improved pricing, and a 2% increase from geographic and product mix. Sales in the beauty segment rose…

America's hiring, and that's supposedly a positive for the economy. But investors are punishing shares of S&P 500 companies adding the most.

What good is a big dividend if the stock keeps falling? Analysts see ways to score dividends on some S&P 500 stocks bucking the sell-off.

Procter & Gamble Co (NYSE:PG) reported second-quarter FY22 sales growth of 6.12% year-on-year, to $20.95 billion, beating the analyst consensus of $20.34 billion. Organic sales increased 6%, driven by a 3% increase in shipment volume, a 3% increase in pricing to help offset the significant commodity and other input cost increases. Sales in…